Abstract：【Objective】To investigate the current status of perimenopausal female sexual dysfunction (FSD) and analyze its risk factors. 【Methods】A total of 246 perimenopausal women who visited Baoji City People's hospital from May 2019 to December 2020 were selected as the survey subjects, and a questionnaire survey was conducted. According to the occurrence of FSD in perimenopausal women, they were divided into the FSD occurrence group and the FSD non-occurring group according. Compare the clinical data of patients in the occurrence group and the non-occurrence group. Logistic multivariate regression analysis of factors affecting the occurrence of FSD during perimenopause. 【Results】The incidence of perimenopausal FSD was 30.49% (75/246). The age, body mass index (BMI), the proportion of diabetes, the proportion of relationship disharmony, and the triglyceride (TG) level of the FSD occurrence group were significantly higher than those of the FSD non-occurring group (P<0.05). The estradiol (E2) level in the FSD occurrence group was significantly lower than that in the FSD non-occurring group (P<0.05). Logistic regression analysis showed that high age, high BMI, and low E2 level were the influencing factors of FSD in menopausal women (OR=3.343, 2.863, 3.861, all P<0.05). 【Conclusion】The incidence of FSD in perimenopausal period is relatively high. Old age, high BMI and reduced E2 level are the influencing factors of FSD in menopausal women.
张福娥, 秦秋燕. 围绝经期女性性功能障碍现状调查及其危险因素分析[J]. 医学临床研究, 2022, 39(1): 98-100.
ZHANG Fu-e, QIN Qiu-yan. Analysis of Sexual Dysfunction Status and Risk Factors in Perimenopausal Women. JOURNAL OF CLINICAL RESEARCH, 2022, 39(1): 98-100.
[1] CLAYTON A H, VALLADARES JUAREZ E M. Female sexual dysfunction[J].Med Clin North Am,2019, 103(4):681-698.
[2] 姚新, 郑春雨, 李婷, 等. 长春市围绝经期女性性功能障碍现状分析[J].中国妇幼保健, 2017,32(3):540-542.
[3] 薛燕, 刘涛. 绝经后妇女激素,脂代谢指标与骨密度对骨质疏松的预测价值[J].医学临床研究,2021, 38(3): 474-476.
[4] 何丽芬, 何志晖. 健康女性性功能障碍709例调查及相关因素分析[J].广东医学, 2018, 39(23):3529-3533.
[5] FAKHRI A, PAKPOUR A H, BURRI A, et al. The Female sexual function index: translation and validation of an Iranian version[J].J Sex Med,2012, 9(2):514-523.
[6] 陈亚, 李致远, 王文第, 等. 妇科良性疾病与女性性功能障碍相关性分析[J].生殖医学杂志, 2017, 25(10):995-999.
[7] GRUENWALD I, LAUTERBACH R, GARTMAN I, et al. Female sexual orgasmic dysfunction and genital sensation deficiency[J].J Sex Med,2020, 17(2):273-278.
[8] 周艳华, 李旭红, 孙绍丹, 等. 物理治疗女性性功能障碍的疗效[J].中南大学学报(医学版), 2018, 43(11):74-78.
[9] 李致远, 党云, 王惠玲, 等. 甘肃省女性性功能障碍患病现况调查及分析[J].实用妇产科杂志, 2018, 34(12):51-54.
[10] THOMAS H N, NEAL-PERRY G S, HESS R. Female sexual function at midlife and beyond[J].Obstet Gynecol Clin North Am,2018, 45(4):709-722.
[11] CORONA G, ISIDORI A M, AVERSA A, BONOMI M,et al. Male and female sexual dysfunction in diabetic subjects: Focus on new antihyperglycemic drugs[J].Rev Endocr Metab Disord,2020, 21(1):57-65.
[12] KRAYNAK M, COLMAN R J, FLOWERS M T,et al. Ovarian estradiol supports sexual behavior but not energy homeostasis in female marmoset monkeys[J].Int J Obes (Lond),2019, 43(5):1034-1045.
[13] RONIS M J, BLACKBURN M L, SHANKAR K,et al. Estradiol and NADPH oxidase crosstalk regulates responses to high fat feeding in female mice[J].Exp Biol Med (Maywood),2019, 244(10):834-845.
2022, Vol. 39 
